IL6 and neoplasm: In addition, recent studies have reported that inhibition of tumor CCRK or liver IL-6 increases interferon γ+ tumor necrosis factor-α+CD8+ T-cell infiltration and impaired tumorigenicity and is restored by recovery of MDSCs.